These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
474 related articles for article (PubMed ID: 28523573)
1. Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn's Disease and Ulcerative Colitis. Lazaridis LD; Pistiki A; Giamarellos-Bourboulis EJ; Georgitsi M; Damoraki G; Polymeros D; Dimitriadis GD; Triantafyllou K Dig Dis Sci; 2017 Sep; 62(9):2348-2356. PubMed ID: 28523573 [TBL] [Abstract][Full Text] [Related]
2. NLRP3-Dependent and -Independent Processing of Interleukin (IL)-1β in Active Ulcerative Colitis. Ranson N; Veldhuis M; Mitchell B; Fanning S; Cook AL; Kunde D; Eri R Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30583612 [TBL] [Abstract][Full Text] [Related]
3. NLRP3 inflammasome has a protective effect against oxazolone-induced colitis: a possible role in ulcerative colitis. Itani S; Watanabe T; Nadatani Y; Sugimura N; Shimada S; Takeda S; Otani K; Hosomi S; Nagami Y; Tanaka F; Kamata N; Yamagami H; Tanigawa T; Shiba M; Tominaga K; Fujiwara Y; Arakawa T Sci Rep; 2016 Dec; 6():39075. PubMed ID: 27966619 [TBL] [Abstract][Full Text] [Related]
4. Heat shock transcription factor 2 reduces the secretion of IL-1β by inhibiting NLRP3 inflammasome activation in ulcerative colitis. Zhang F; Zhao W; Zhou J; Wang W; Luo J; Feng Y; Wu J; Li M; Wang K; Niu J; Miao Y Gene; 2021 Feb; 768():145299. PubMed ID: 33181254 [TBL] [Abstract][Full Text] [Related]
5. Growth differentiation factor 11 ameliorates experimental colitis by inhibiting NLRP3 inflammasome activation. Wang L; Wang Y; Wang Z; Qi Y; Zong B; Liu M; Li X; Zhang X; Liu C; Cao R; Ma Y Am J Physiol Gastrointest Liver Physiol; 2018 Dec; 315(6):G909-G920. PubMed ID: 30188752 [TBL] [Abstract][Full Text] [Related]
6. Galectin-3 Plays an Important Pro-inflammatory Role in the Induction Phase of Acute Colitis by Promoting Activation of NLRP3 Inflammasome and Production of IL-1β in Macrophages. Simovic Markovic B; Nikolic A; Gazdic M; Bojic S; Vucicevic L; Kosic M; Mitrovic S; Milosavljevic M; Besra G; Trajkovic V; Arsenijevic N; Lukic ML; Volarevic V J Crohns Colitis; 2016 May; 10(5):593-606. PubMed ID: 26786981 [TBL] [Abstract][Full Text] [Related]
7. The Pathogenic Role of NLRP3 Inflammasome Activation in Inflammatory Bowel Diseases of Both Mice and Humans. Liu L; Dong Y; Ye M; Jin S; Yang J; Joosse ME; Sun Y; Zhang J; Lazarev M; Brant SR; Safar B; Marohn M; Mezey E; Li X J Crohns Colitis; 2017 Jun; 11(6):737-750. PubMed ID: 27993998 [TBL] [Abstract][Full Text] [Related]
8. Increased expression of NLRP3 inflammasome components and interleukin-18 in patients with bullous pemphigoid. Fang H; Shao S; Cao T; Lei J; Dang E; Zhang J; Wang G J Dermatol Sci; 2016 Aug; 83(2):116-23. PubMed ID: 27174093 [TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of NLRP3 inflammasome-related inflammation in peripheral blood mononuclear cells in Sjögren's syndrome. Kim SK; Choe JY; Lee GH Clin Chim Acta; 2017 Nov; 474():147-154. PubMed ID: 28965771 [TBL] [Abstract][Full Text] [Related]
10. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome. Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790 [TBL] [Abstract][Full Text] [Related]
11. Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome. De la Fuente M; Franchi L; Araya D; Díaz-Jiménez D; Olivares M; Álvarez-Lobos M; Golenbock D; González MJ; López-Kostner F; Quera R; Núñez G; Vidal R; Hermoso MA Int J Med Microbiol; 2014 May; 304(3-4):384-92. PubMed ID: 24581881 [TBL] [Abstract][Full Text] [Related]
12. [Role of NLRP1 and NLRP3 inflammasome signaling pathways in the immune mechanism of inflammatory bowel disease in children]. Wang H; Ma YC Zhongguo Dang Dai Er Ke Za Zhi; 2020 Aug; 22(8):854-859. PubMed ID: 32800032 [TBL] [Abstract][Full Text] [Related]
13. DNA sensor-associated type I interferon signaling is increased in ulcerative colitis and induces JAK-dependent inflammatory cell death in colonic organoids. Flood P; Fanning A; Woznicki JA; Crowley T; Christopher A; Vaccaro A; Houston A; McSweeney S; Ross S; Hogan A; Brint E; Skowyra A; Bustamante M; Ambrose M; Moloney G; MacSharry J; Hammarström ML; Hurley M; Fitzgibbons C; Quigley EMM; Shanahan F; Zulquernain SA; McCarthy J; Dodson GS; Dabbagh K; McRae BL; Melgar S; Nally K Am J Physiol Gastrointest Liver Physiol; 2022 Nov; 323(5):G439-G460. PubMed ID: 36165492 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation. Du X; Chen W; Wang Y; Chen C; Guo L; Ju R; Li J; Zhang D; Zhu L; Ye C Int Immunopharmacol; 2017 Apr; 45():16-25. PubMed ID: 28152446 [TBL] [Abstract][Full Text] [Related]
16. 3-(2-Oxo-2-phenylethylidene)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (compound 1), a novel potent Nrf2/ARE inducer, protects against DSS-induced colitis via inhibiting NLRP3 inflammasome. Wang Y; Wang H; Qian C; Tang J; Zhou W; Liu X; You Q; Hu R Biochem Pharmacol; 2016 Feb; 101():71-86. PubMed ID: 26588861 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of NLRP3 inflammasome components in Mooren's ulcer. Li Z; Wei C; Wang S; Liu T; Zhai H; Shi W Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):607-612. PubMed ID: 27796668 [TBL] [Abstract][Full Text] [Related]
18. Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease. Vainer B; Nielsen OH; Hendel J; Horn T; Kirman I Cytokine; 2000 Oct; 12(10):1531-6. PubMed ID: 11023669 [TBL] [Abstract][Full Text] [Related]
19. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages. Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403 [TBL] [Abstract][Full Text] [Related]
20. Targeting NLRP3 Inflammasome in Inflammatory Bowel Disease: Putting out the Fire of Inflammation. Shao BZ; Wang SL; Pan P; Yao J; Wu K; Li ZS; Bai Y; Linghu EQ Inflammation; 2019 Aug; 42(4):1147-1159. PubMed ID: 30937839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]